Location History:
- 6300 Giessen, DE (1983 - 1985)
- 6300 Giessen 1, DE (1987)
Company Filing History:
3 out of 832,812 Years Active: 1983-1987
Title: The Innovations of Hansjorg Teschemacher: A Pioneer in Pharmacologically Active Peptides
Introduction
Hansjorg Teschemacher, an inventor based in Giessen, Germany, is known for his significant contributions to the field of pharmacology through the development of innovative peptides. With a total of three patents to his name, Teschemacher's work has the potential to influence medical science and therapeutic approaches.
Latest Patents
Teschemacher's latest patents focus on pharmacologically active peptides. One notable patent is centered around a specific group of peptides represented by the formula Tyr^1 -X-A-Pro-B-Pro-C-Pro-D. In this formulation, Tyr^1 corresponds to the amino acid tyrosine, while Pro signifies proline. The variables A, B, C, and D can represent any desirable amino acid in the L-form, alongside X, which denotes any amino acid in the D-form, with certain exclusions. These peptides exhibit opiate-like properties and are poised to serve as both medicaments and veterinary medicine alternatives, showcasing Teschemacher's ability to merge creative invention with practical healthcare applications.
Career Highlights
Throughout his career, Hansjorg Teschemacher has remained dedicated to research and innovation in pharmacology. His focus on peptide chemistry has positioned him at the forefront of this evolving field. With three patents highlighting his work, his inventions have the potential to address various medical needs, reinforcing his status as a notable inventor.
Collaborations
Collaboration is a key component of innovation, and Teschemacher has worked alongside esteemed colleagues such as Victor Brantl and Agnes Henschen. These partnerships enhance his research capabilities and facilitate the advancement of new ideas within the domain of pharmacological innovations.
Conclusion
In conclusion, Hansjorg Teschemacher is a distinguished inventor whose patented work with pharmacologically active peptides contributes to the landscape of modern medicine. His efforts, combined with collaborative support from talented colleagues, pave the way for future advancements in pharmacology, highlighting the importance of innovation in improving healthcare outcomes.